Novo Nordisk Stock Rises as Weight Loss Drugs Drive Growth, Cautious Outlook for 2025
Strong sales of its weight loss and diabetes medications, Ozempic and Wegovy, have continued to boost pharmaceutical giant Novo Nordisk, fueling its growth throughout the past year. The company performed better than expected. However, CEO…
